100 related articles for article (PubMed ID: 26480648)
1. [Effect of Recombinant Super-compound Interferon (rSIFN-co) on Proliferation and Apoptosis of Human Pulmonary Adenocarcinoma Cell A549].
Kan QW; Liu LX; Wei GW; Pu Q; Zhuge XP; Ma L; Ma JL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Jul; 46(4):508-12. PubMed ID: 26480648
[TBL] [Abstract][Full Text] [Related]
2. [Effect of recombinant super-compound interferon (rSIFN-co) on human breast cancer cells in vitro].
Zheng J; Lü Q; Wei DP
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 41(1):29-34, 48. PubMed ID: 20369465
[TBL] [Abstract][Full Text] [Related]
3. [Effect of cisplatin alone or combined with monoclonal anti-programmed death ligand-1 antibody on lung adenocarcinoma cell line SPCA-1 and T lymphocytes].
Pan X; Xing Y; Shi M; Zhou T; Qian B; Chen Y
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jun; 37(6):416-20. PubMed ID: 25200040
[TBL] [Abstract][Full Text] [Related]
4. [Study on the susceptibility of the cervical carcinoma cells to CTL lysis under the stimulation of rSIFN-co and its mechanism].
Chen Y; He YD; Pan XL; Liu X; Lai ZZ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):715-8. PubMed ID: 19024297
[TBL] [Abstract][Full Text] [Related]
5. Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells.
Wang CK; Zhang Y; Zhang ZJ; Qiu QW; Cao JG; He ZM
Oncol Rep; 2015 Jan; 33(1):372-82. PubMed ID: 25394854
[TBL] [Abstract][Full Text] [Related]
6. [The roles of holothurian glycosaminoglycan combined with cisplatin on proliferation and chemotherapeutic response in A549 human lung adenocarcinoma cell].
Jin Q; Zhu XH; Lin CZ; Zhang H; Cao YW; Ding XQ; Lyu ZH
Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):252-257. PubMed ID: 29730910
[No Abstract] [Full Text] [Related]
7. [Effect of down-regulation of survivin gene on apoptosis and cisplatin resistance in cisplatin resistant human lung adenocarcinoma A549/CDDP cells].
Zhang MC; Hu CP; Chen Q
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):408-12. PubMed ID: 17152483
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of sorafenib on the A549/DDP human lung adenocarcinoma cell line in vitro.
Chen XQ; Wang YL; Li ZY; Lin TY
Mol Med Rep; 2014 Jul; 10(1):347-52. PubMed ID: 24788469
[TBL] [Abstract][Full Text] [Related]
9. [Synergistic Antitumor Effect of Amorphigenin Combined with Cisplatin in Human Lung Adenocarcinoma A549/DDP Cells].
Zhong H; Zuo Y; Wu X; Peng Y; He H; Yang J; Guan C; Xu Z
Zhongguo Fei Ai Za Zhi; 2016 Dec; 19(12):805-812. PubMed ID: 27978865
[TBL] [Abstract][Full Text] [Related]
10. [Examination of resistance of lung adenocarcinoma cells to cisplatin by technetium-99m methoxyisobutyl isonitrile].
Hu S; Hu CP; Liang CH
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1493-8. PubMed ID: 16061030
[TBL] [Abstract][Full Text] [Related]
11. [Increased expression of acetaldehyde dehydrogenase in cisplatin-resistant human lung adenocarcinoma A549/DDP cells].
He J; Song X; Yu L; Li J; Qiao Z; Jiu R; Yu B; Liu X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 May; 31(5):625-9. PubMed ID: 25940289
[TBL] [Abstract][Full Text] [Related]
12. [The effects of Tumstatin185-191 on lung adenocarcinoma cell lines and the association with protein kinase B and extracellular regulated protein kinase activation].
Wang W; Chen P; Li JL; Pei YF; Shuang QC; Liu CH; Cai S; Liu SK; Zhu LY; Zhou R
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Feb; 33(2):123-7. PubMed ID: 20367953
[TBL] [Abstract][Full Text] [Related]
13. GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin.
Gong X; Liu J; Zhang D; Yang D; Min Z; Wen X; Wang G; Li H; Song Y; Bai C; Li J; Zhou J
PLoS One; 2017; 12(8):e0182410. PubMed ID: 28771580
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin induces expression of drug resistance-related genes through c-jun N-terminal kinase pathway in human lung cancer cells.
Xu L; Fu Y; Li Y; Han X
Cancer Chemother Pharmacol; 2017 Aug; 80(2):235-242. PubMed ID: 28597042
[TBL] [Abstract][Full Text] [Related]
15. [The effect of Bcl-2 gene silencing on the sensitivity of cell line A549 to chemotherapeutic drugs].
Wang JQ; Du ZW; Gao XF; Wu M; Zhang YC; Pan Y; Wang Q; Zhang GZ
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):191-7. PubMed ID: 23856142
[TBL] [Abstract][Full Text] [Related]
16. rmhTNF-α combined with cisplatin inhibits proliferation of A549 cell line in vitro.
Xia LM; Zhou YY
Chin Med Sci J; 2014 Sep; 29(3):185-7. PubMed ID: 25264888
[TBL] [Abstract][Full Text] [Related]
17. [Effects of GM3 on proliferation, apoptosis and VEGF expression in human lung adenocarcinoma cell line A549 cells].
Zhu Y; Wu G; Chen J; Zhu F; Ren JH; Li ZY; Zhang RG; Sun Y
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):251-5. PubMed ID: 21575493
[TBL] [Abstract][Full Text] [Related]
18. C-Myc participates in β-catenin-mediated drug resistance in A549/DDP lung adenocarcinoma cells.
Xie C; Pan Y; Hao F; Gao Y; Liu Z; Zhang X; Xie L; Jiang G; Li Q; Wang E
APMIS; 2014 Dec; 122(12):1251-8. PubMed ID: 25131138
[TBL] [Abstract][Full Text] [Related]
19. β-Catenin signaling pathway regulates cisplatin resistance in lung adenocarcinoma cells by upregulating Bcl-xl.
Zhang J; Liu J; Li H; Wang J
Mol Med Rep; 2016 Mar; 13(3):2543-51. PubMed ID: 26860078
[TBL] [Abstract][Full Text] [Related]
20. Co-transfection of MRP and bcl-2 antisense S-oligodeoxynucleotides reduces drug resistance in cisplatin-resistant lung cancer cells.
Wang J; Liu X; Jiang W
Chin Med J (Engl); 2000 Oct; 113(10):957-60. PubMed ID: 11775848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
